ICU Medical reports Q3 revenue down 7.5% to $553.3M; GAAP EPS $0.30 vs loss, adjusted EPS $1.57

ICU MEDICAL INC/DE

2023-Q3 EPS reported -$0.52 revenue$1,671,270,000

Revenue $553.3M vs $597.9M YoY (-7.5%), GAAP net income $7.2M ($0.30 diluted) vs loss of $13.2M.
Adjusted diluted EPS $1.57 vs $1.75 YoY; adjusted EBITDA $89.8M vs $92.6M.
GAAP gross margin improved to 33% from 31% in Q3 2022.
No forward guidance provided in the release.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ICU MEDICAL INC/DE reported third quarter of 2023 results: revenue $553.3 million, net income $7.2 million, EPS $0.30 per diluted share.

Period: third quarter of 2023
Revenue: $553.3 million
Net income: $7.2 million
EPS: $0.30 per diluted share
Result: reported results

Exact text from the filing

Third quarter 2023 revenue was $553.3 million, compared to $597.9 million in the same period last year.

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

ICU MEDICAL INC/DE filing history →

Source: SEC EDGAR

accession 0000883984-23-000037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.